S&P 500   3,803.63
DOW   30,983.88
QQQ   316.32
S&P 500   3,803.63
DOW   30,983.88
QQQ   316.32
S&P 500   3,803.63
DOW   30,983.88
QQQ   316.32
S&P 500   3,803.63
DOW   30,983.88
QQQ   316.32
Log in
OTCMKTS:SARTF

Sartorius Aktiengesellschaft Stock Forecast, Price & News

$420.00
+10.70 (+2.61 %)
(As of 01/15/2021 08:27 PM ET)
Add
Compare
Today's Range
$420.00
Now: $420.00
$420.00
50-Day Range
$395.00
MA: $411.14
$420.00
52-Week Range
$214.10
Now: $420.00
$425.00
Volume100 shs
Average Volume1 shs
Market Capitalization$14.37 billion
P/E Ratio150.54
Dividend YieldN/A
Beta0.58
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers live cell analysis system, and cell analysis reagents and consumables; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. It also provides lab filtration and purification devices; sterile and virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, and integrity testing devices; and liquid storage and shipping, freeze and thaw, mixing, proven integrity, transferring and sampling, connecting and disconnecting, and final filling management products. In addition, the company offers process control and data analytics products, such as process analyzers, automation modules, and data analytics and chemometrics; and microbiology products, and lab water purification systems. Further, it provides lab balances, mass comparators and metrology, moisture analyzers, specialty weighing solutions, weighing accessories, weights/weight sets, paint mixing solutions, and OEM weigh cells; and OEM membrane and device, pipetting and dispensing, and connectivity solutions. Additionally, the company offers bioprocess development engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, cannabis testing, food and beverage, environmental, and paint mixing industries. Sartorius Aktiengesellschaft and Evotec SE has a partnership with Curexsys GmbH on iPSC-based therapeutic exosome approach. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Sartorius Aktiengesellschaft logo

MarketRank

Overall MarketRank

0.84 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SARTF
Previous SymbolNASDAQ:SARTF
CUSIPN/A
CIKN/A
Phone49-55-130-80
Employees6,203

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.61 billion
Cash Flow$11.29 per share
Book Value$38.55 per share

Profitability

Net Income$262.72 million

Miscellaneous

Market Cap$14.37 billion
Next Earnings Date2/16/2021 (Estimated)
OptionableNot Optionable
$420.00
+10.70 (+2.61 %)
(As of 01/15/2021 08:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SARTF News and Ratings via Email

Sign-up to receive the latest news and ratings for SARTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Frequently Asked Questions

How has Sartorius Aktiengesellschaft's stock price been impacted by Coronavirus?

Sartorius Aktiengesellschaft's stock was trading at $224.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SARTF shares have increased by 87.5% and is now trading at $420.00.
View which stocks have been most impacted by COVID-19
.

Is Sartorius Aktiengesellschaft a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sartorius Aktiengesellschaft in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Sartorius Aktiengesellschaft stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SARTF, but not buy additional shares or sell existing shares.
View analyst ratings for Sartorius Aktiengesellschaft
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Sartorius Aktiengesellschaft?

Wall Street analysts have given Sartorius Aktiengesellschaft a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sartorius Aktiengesellschaft wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Sartorius Aktiengesellschaft's next earnings date?

Sartorius Aktiengesellschaft is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Sartorius Aktiengesellschaft
.

Who are some of Sartorius Aktiengesellschaft's key competitors?

Who are Sartorius Aktiengesellschaft's key executives?

Sartorius Aktiengesellschaft's management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 55)
  • Mr. Rainer Lehmann, CFO, Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 44)
  • Mr. John Gerard Mackay, Head of Lab Products & Services Division and Member of Exec. Board (Age 58)
  • Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 45)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 51)
  • Mr. Manfred Werner, Sr. VP of Admin. Organization & Auditing
  • Ms. Mei Wang, Head of Production - China
  • Ms. Patricia Spannagel, Head of Quality Assurance - Mechatronics Division Goettingen
  • Mr. Rashid Maqbool, Head of Production & Certification Department - Denver USA
  • Mr. Manohar Kuppusami, Head of Production Department - India

What is Sartorius Aktiengesellschaft's stock symbol?

Sartorius Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "SARTF."

How do I buy shares of Sartorius Aktiengesellschaft?

Shares of SARTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sartorius Aktiengesellschaft's stock price today?

One share of SARTF stock can currently be purchased for approximately $420.00.

How big of a company is Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft has a market capitalization of $14.37 billion and generates $1.61 billion in revenue each year. The company earns $262.72 million in net income (profit) each year or $3.19 on an earnings per share basis. Sartorius Aktiengesellschaft employs 6,203 workers across the globe.

What is Sartorius Aktiengesellschaft's official website?

The official website for Sartorius Aktiengesellschaft is www.sartorius.com.

How can I contact Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft's mailing address is OTTO-BRENNER-STRASSE 20, GOETTINGEN 2M, 37079. The company can be reached via phone at 49-55-130-80 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.